Key Insights

Highlights

Success Rate

50% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 65/100

Termination Rate

5.6%

1 terminated out of 18 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

17%

3 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (7)
P 2 (3)
P 3 (1)
P 4 (2)

Trial Status

Recruiting9
Not Yet Recruiting7
Terminated1
Completed1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07241390Phase 3RecruitingPrimary

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

NCT07665034Not ApplicableRecruitingPrimary

Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

NCT07263113Not ApplicableRecruiting

Evaluation of the Association Between the Effects of Generalized Stage 3 and 4 Periodontitis on Arterial Stiffness and Cardiovascular Risk: the PAROCAR Study

NCT07641257Not Yet Recruiting

Effects of Icosapent Ethyl on Coronary Plaque, Inflammation, and Ventricular Remodeling

NCT07303777Phase 2RecruitingPrimary

Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

NCT07296965RecruitingPrimary

Oral Microbiome in Carotid Atherosclerosis

NCT07474233Not Yet RecruitingPrimary

Associations Between Dietary Patterns, LDL Aggregation, and Cardiometabolic Health: A Cross-sectional Analysis.

NCT07462871Not ApplicableNot Yet RecruitingPrimary

Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health

NCT07422051Phase 2Not Yet RecruitingPrimary

Erythrodiol in Pomace Olive Oil as a Protective Agent Against Atherosclerosis

NCT07361887Not ApplicableRecruitingPrimary

Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.

NCT06626659Completed

Lipoprotein (a) and Vascular Regenerative Cell Content

NCT07237685Recruiting

Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus

NCT07104487Phase 2Recruiting

[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease

NCT06606821Phase 4Recruiting

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

NCT06856772Phase 4Not Yet Recruiting

Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial

NCT06720662Not ApplicableNot Yet RecruitingPrimary

Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease.

NCT06731400Not ApplicableNot Yet RecruitingPrimary

Variability in Human Fatty Acids Profiles Based on Blood Fractions and Metabolic Conditions

NCT03734887Not ApplicableTerminated

Social Engagement Strategies to Improve Medication Adherence

Showing all 18 trials

Research Network

Activity Timeline